HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA-A33 and -B44 and susceptibility to postherpetic neuralgia (PHN).

Abstract
HLA class I and class II alleles of 32 Japanese patients with postherpetic neuralgia (PHN) and 136 healthy controls were analyzed by serological (class I) and DNA (class II) typing for any significance in the susceptibility to varicella-zoster virus (VZV). We recognized positive associations of the development of PHN with the HLA class I antigens HLA-A33 and -B44, and the HLA-A33-B44 haplotype. This haplotype is tightly linked to DRB1*1302 in a Japanese healthy population. However, no significant association between PHN and HLA class II alleles was observed with no linkage of the HLA haplotype HLA-A33-B44 to HLA-DRB1*1302 in the patients with PHN. These findings suggest that HLA class I gene may genetically control the immune response against VZV in the pathogenesis of PHN.
AuthorsA Ozawa, Y Sasao, K Iwashita, M Miyahara, J Sugai, M Iizuka, Y Kawakubo, M Ohkido, T Naruse, T Anzai, N Takashige, A Ando, H Inoko
JournalTissue antigens (Tissue Antigens) Vol. 53 Issue 3 Pg. 263-8 (Mar 1999) ISSN: 0001-2815 [Print] England
PMID10203019 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-A Antigens
  • HLA-A*33 antigen
  • HLA-B Antigens
  • HLA-B44 Antigen
  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II
Topics
  • Aged
  • Aged, 80 and over
  • Alleles
  • Female
  • Genetic Predisposition to Disease
  • HLA-A Antigens (genetics, immunology)
  • HLA-B Antigens (genetics, immunology)
  • HLA-B44 Antigen
  • Herpesviridae Infections (complications, immunology)
  • Herpesvirus 3, Human (immunology)
  • Histocompatibility Antigens Class I (genetics)
  • Histocompatibility Antigens Class II (genetics)
  • Humans
  • Male
  • Middle Aged
  • Neuralgia (etiology, genetics)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: